Rehmann Capital Advisory Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.9K | Sell |
|
|||||
|
2025
Q1 | $86.4K | Hold |
|
|||||
|
2024
Q4 | $86.6K | Sell |
|
|||||
|
2024
Q3 | $90.9K | Sell |
|
|||||
|
2024
Q2 | $74.2K | Sell |
|
|||||
|
2024
Q1 | $61.3K | Hold |
|
|||||
|
2023
Q4 | $72.3K | Sell |
|
|||||
|
2023
Q3 | $86K | Hold |
|
|||||
|
2023
Q2 | $85.5K | Hold |
|
|||||
|
2023
Q1 | $101K | Hold |
|
|||||
|
2022
Q4 | $139K | Hold |
|
|||||
|
2022
Q3 | $153K | Hold |
|
|||||
|
2022
Q2 | $128K | Hold |
|
|||||
|
2022
Q1 | $197K | Hold |
|
|||||
|
2021
Q4 | $168K | Buy |
|